LORENA GALINDO REGAL

Mrs. LORENA GALINDO REGAL

FISABIO, Valencia, Spain
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
FRFernando Redondo
Fernando Redondo
CMCAROLINA HURTADO MARCOS
CAROLINA HURTADO MARCOS
FIFernando Izquierdo
Fernando Izquierdo
CHCarmen Cuellar del Hoyo
Carmen Cuellar del Hoyo
SFSoledad Fenoy
Soledad Fenoy
Juan Carlos Andreu-BallesterJuan Carlos Andreu-Ballester
Juan Carlos Andreu-Ballester
Microsporidia are opportunistic intracellular parasites, generating serious pathology in individuals with a compromised immune system. Infection by microsporidia inhibits p53 and Caspase 3, proteins involved in apoptosis and the cell cycle, which are vital in the malignant process of epithelial cells. The presence of microsporidia in the intestinal tissues of 87 colon cancer (CC) patients and 25 healthy controls was analyzed by real-time PCR and an immunofluorescence antibody test. Anti-Encephalitozoon antibodies were analyzed in serum samples by ELISA (enzyme linked immunosorbent assay). In 36 (41.3%) CC cases, microsporidia infections were identified in their tissues vs. no cases among control subjects (p < 0.0001). An increase in IgG and IgE anti-Encephalitozoon antibodies was found in patients with CC, which would demonstrate continuous and previous contact with the parasite. The high prevalence of microsporidia in tissues and the seroprevalence in patients with CC suggest a relationship between microsporidia and the etiopathogenesis of CC.

16 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Juan Carlos Andreu-BallesterJuan Carlos Andreu-Ballester
Juan Carlos Andreu-Ballester
LRLORENA GALINDO REGAL
LORENA GALINDO REGAL
JHJulia Hidalgo-Coloma
Julia Hidalgo-Coloma
CHCarmen Cuellar del Hoyo
Carmen Cuellar del Hoyo
CGCarlos García-Ballesteros
Carlos García-Ballesteros
ALANTONIO LLOMBART-CUSSAC
ANTONIO LLOMBART-CUSSAC
Downregulation of the T cell system has been proposed as a mechanism to block immunity in colonic cancer (CC). However, little has been studied about circulating αβ and γδ T cells and their immunological status in newly diagnosed patients. The aim of this study was to characterize the αβ and γδ T cell subsets in peripheral blood of patients with CC matched with healthy volunteers. In this prospective case-control study, blood samples were obtained from 96 patients with newly diagnosed treatment-naïve infiltrating colonic adenocarcinoma and 48 healthy volunteers. Pathological report at surgery was obtained from all CC patients. A significant decrease in CD3+ γδ T cells and CD3+CD8+ γδ T cells (p<0.001) were observed in CC patients. Apoptosis was significantly increased in all conventional and both αβ and γδ T cell subsets in patients with CC vs healthy subjects. γδ T cells were decreased in peripheral blood of patients with microscopic infiltration in tissues, history of cancer and synchronous colon cancer (p < 0.05). IFN-γ was significantly reduced in CC patients compared to controls. Cytotoxic effector γδ T cells TEMRA (CD8 and CD56) are the proportionally most abundant T cells in peripheral blood of CC patients. Patients with CC present a deep downregulation in the systemic T-cell immunity. These variations are evident through all tumor stages and suggest that a deficiency in γδ T cell populations could be preventing control of tumor progression. This fact prove the role of immunomodulation on CC carcinogenesis.

18 May 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Juan Carlos Andreu-BallesterJuan Carlos Andreu-Ballester
Juan Carlos Andreu-Ballester
LRLORENA GALINDO REGAL
LORENA GALINDO REGAL
CHCarmen Cuellar del Hoyo
Carmen Cuellar del Hoyo
FLFrancisca López-Chuliá
Francisca López-Chuliá
CGCarlos García-Ballesteros
Carlos García-Ballesteros
VDVICTORIA DOMINGUEZ-MARQUEZ
VICTORIA DOMINGUEZ-MARQUEZ
Background: The COVID-19 pandemic is the biggest global health problem in the last hundred years. The efficacy of the vaccine to protect against severe disease is estimated to be 70–95% according to the studies carried out, although there are aspects of the immune response to the vaccine that remain unclear. Methods: Humoral and cellular immunity after the administration of three doses of the Pfizer–BioNTech and Oxford AstraZeneca vaccines against SARS-CoV-2 over one year and the appearance of post-vaccination COVID-19 were studied. SARS-CoV-2 IgG and IgA antibodies, αβ and γδ T-cell subsets, and their differentiation stages and apoptosis were analyzed. Results: Anti-SARS-CoV-2 IgG and IgA antibodies showed a progressive increase throughout the duration of the study. This increase was the greatest after the third dose. The highest levels were observed in subjects who had anti-SARS-CoV-2 antibodies prior to vaccination. There was an increase in CD4+ αβ, CD8+ γδ and TEM CD8+ γδ T cells, and a decrease in apoptosis in CD4+ CD8+ and CD56+ αβ and γδ T cells. Post-vaccination SARS-CoV-2 infection was greater than 60%. The symptoms of COVID-19 were very mild and were related to a γδ T cell deficit, specifically CD8+ TEMRA and CD56+ γδ TEM, as well as lower pre-vaccine apoptosis levels. Conclusions: The results unveil the important role of γδ T cells in SARS-CoV-2-vaccine-mediated protection from the disease.

27 November 2024 in Antibodies
Verified
Journal Article
Open access
Juan Carlos Andreu-BallesterJuan Carlos Andreu-Ballester
Juan Carlos Andreu-Ballester
ANAmparo Navarro
Amparo Navarro
MSMiguel Angel Arribas Santamaria
Miguel Angel Arribas Santamaria
MRMoises Rico
Moises Rico
LALaura Albert
Laura Albert
CHCarmen Cuellar del Hoyo
Carmen Cuellar del Hoyo
Background/Objectives: In a previous study, we described elevated anti-Anisakis IgG levels in septic patients in relation to disease severity. In this study, our objective was to analyze the evolution of anti-Anisakis immunoglobulins in septic patients during hospital admission and their association with αβ and γδ T cell subsets. Methods: We recruited 80 subjects: 40 patients with sepsis and 40 controls. αβ and γδ T cells were analyzed using flow cytometry. Apoptosis was also assessed, and anti-Anisakis antibodies were measured by ELISA in the sera of patients with sepsis and controls. Results: In the second analysis (7–10 after sepsis evolution), an increase in all specific antibody isotypes was identified in individuals with septic shock, except IgE. The levels of anti-Anisakis IgG and IgA were higher in the subjects with sepsis in the first analysis and continued to increase in the second analysis compared with the healthy control subjects. There was an increase in anti-Anisakis IgG and IgA levels in surviving patients and an increase in IgA levels in non-surviving patients. A rise in specific IgG and IgE levels was noted in the second analysis of patients with sepsis with αβ CD3+ T cell deficiency. Patients without γδ T cell deficiency had increased anti-Anisakis IgA levels 7–10 days after admission. Conclusions: Our results suggest a previous infection by Anisakis that could be involved in the subsequent septic process and be related to patients who have negative cultures in which the pathogen causing sepsis has not been identified.

17 April 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Juan Carlos Andreu-BallesterJuan Carlos Andreu-Ballester
Juan Carlos Andreu-Ballester
LRLORENA GALINDO REGAL
LORENA GALINDO REGAL
CHCarmen Cuellar del Hoyo
Carmen Cuellar del Hoyo
FLFrancisca López-Chuliá
Francisca López-Chuliá
CGCarlos García-Ballesteros
Carlos García-Ballesteros
VDVICTORIA DOMINGUEZ-MARQUEZ
VICTORIA DOMINGUEZ-MARQUEZ
Background: The effectiveness of the anti-COVID-19 vaccine remains a matter to be clarified. Methods: The humoral and cellular immunity after the administration of three doses of the Pfizer–BioNTech and Oxford AstraZeneca vaccines against SARS-CoV-2 over one year and the appearance of post-vaccination COVID-19 have been studied. Results: Anti-SARS-CoV-2 IgG and IgA antibodies showed a progressive increase throughout the vaccination period. This increase was greatest after the third dose. The highest levels were observed in subjects who had anti-SARS-CoV-2 antibodies prior to vaccination. There was an increase in CD4+ αβ, CD8+ γδ and TEM CD8+ γδ T cells, and a decrease in apoptosis in CD4+CD8+ and CD56+ αβ and γδ T cells. Post-vaccination SARS-CoV-2 infection was greater than 60%. The symptoms of COVID-19 were very mild and were related to γδ T cell deficit, specifically CD8+ TEMRA and CD56+ γδ TEM, as well as lower pre-vaccine apoptosis levels. Conclusions: Those results demonstrate the important role that γδ T cells play in SARS-CoV-2 vaccine immunization.

15 July 2026 in Cancers
Verified
Journal Article
Open access
PDF file
Juan Carlos Andreu-BallesterJuan Carlos Andreu-Ballester
Juan Carlos Andreu-Ballester
CACirilo Amorós-García
Cirilo Amorós-García
SBSalvador Benlloch
Salvador Benlloch
LRLORENA GALINDO REGAL
LORENA GALINDO REGAL
CGCarlos García-Ballesteros
Carlos García-Ballesteros
CMCAROLINA HURTADO MARCOS
CAROLINA HURTADO MARCOS
Background/Objectives: Colorectal cancer commonly develops through an adenoma–carcinoma sequence, but the immune alterations accompanying this transition remain incompletely understood. Because we previously observed reduced γδ T cells, increased apoptosis, and frequent microsporidia infection in colorectal cancer, we investigated whether similar changes are already present in colonic adenomas. Methods: We studied 55 subjects, including 30 patients with colonic adenomas, 10 with colorectal cancer, and 15 healthy controls. Peripheral blood T-cell subsets and apoptosis were assessed by flow cytometry, tissue expression of IL-7, CD127, and CD132 was analyzed by RT-PCR, and microsporidia were detected in colonic tissues by immunofluorescence and real-time PCR. Results: γδ T cells were progressively reduced in colonic adenomas and further decreased in colorectal cancer, while apoptosis of both αβ and γδ T cells increased compared with healthy subjects. Tissue expression of CD132 was significantly downregulated in adenomas and colorectal cancer, whereas IL-7 expression was increased, particularly in adenomatous tissue, consistent with a compensatory mechanism attempting to preserve T-cell homeostasis despite reduced CD132 expression. Microsporidia prevalence rose from healthy controls to patients with colonic adenomas and colorectal cancer, and CD132 expression was more markedly reduced in microsporidia-positive colonic adenoma and cancer tissues. Conclusions: These findings indicate that altered IL-2 receptor-related signaling, γδ T-cell depletion, and increased apoptosis are already present at the adenoma stage and are associated with microsporidial infection. This pattern suggests a potential link between parasitic colonization and local immune dysfunction during colorectal tumorigenesis.